1.Ischaemic stroke in young adults: A comparative study between Malaysia and Australia
Kay Sin Tan ; Chong Tin Tan ; Leonid Churilov ; Mark Mackay ; Geoffrey A Donnan
Neurology Asia 2010;15(1):1-9
Background and Objectives: There is a paucity of comparative studies on young strokes between
populations of different ethnicities and geographical regions. The purpose of this study was to compare
the patterns, risk factors and etiologies of ischaemic stroke in younger patients between stroke registries
in Malaysia and Australia. Methods: From January 2007 to March 2008, all consecutive ischaemic
stroke patients from the age of 18 to 49 were studied. Results: There were 67 patients for Malaysia
and 61 for Australia, with 4 deaths in the Malaysian series (case-fatality of 6%), and no deaths for
Australia. The mean age was 41.5±8.8 yrs for Malaysia and 40.1±8.8 years for Australia. The ethnic
origin was Malays, Chinese and Indian for Malaysia, and Caucasians (85%) for Australia. The sex
ratio was M : F = 1.4 : 1 for Malaysia and 1.54 :1 for Australia. The differences in risk factors for
Malaysia versus Australia were: Diabetes (OR 7.25; 95% CI 2.78-19.45), hypertension (OR 6.42;
95% CI 2.75-15.22) and chronic renal disease (OR 5.2; 95% CI 1.02-35.87). Conversely, smoking
was a signifi cant risk factor for Australia (OR 2.75; 95% CI 1.2-6.37). The Malaysian patients have
signifi cantly higher proportions of large vessel atherosclerosis and small vessel occlusion by TOAST
classifi cation, accounting for 60% of patients, while the Australian series had greater proportions of
cardioembolism and patients in the determined aetiologies category, specifi cally vascular dissection.
Conclusion: There were signifi cantly more large vessel atherosclerosis and small vessel occlusion
among young Malaysians with ischaemic stroke as compared to Australia.
2.Blood Pressure May Be Associated with Arterial Collateralization in Anterior Circulation Ischemic Stroke before Acute Reperfusion Therapy.
Beisi JIANG ; Leonid CHURILOV ; Lasheta KANESAN ; Richard DOWLING ; Peter MITCHELL ; Qiang DONG ; Stephen DAVIS ; Bernard YAN
Journal of Stroke 2017;19(2):222-228
BACKGROUND AND PURPOSE: Leptomeningeal collaterals maintain arterial perfusion in acute arterial occlusion but may fluctuate subject to arterial blood pressure (ABP). We aim to investigate the relationship between ABP and collaterals as assessed by computer tomography (CT) perfusion in acute ischemic stroke. METHODS: We retrospectively analyzed acute anterior circulation ischemic stroke patients with CT perfusion from 2009 to 2014. Collateral status using relative filling time delay (rFTD) determined by time delay of collateral-derived contrast opacification within the Sylvian fissure, from 0 seconds to unlimited count. The data were analyzed by zero-inflated negative binomial regression model including an appropriate interaction examining in the model in terms of occlusion location and onset-to-CT time (OCT). RESULTS: Two hundred and seventy patients were included. We found that increment of 10 mm Hg in BP, the odds that a patient would have rFTD equal to 0 seconds increased by 27.9% in systolic BP (SBP) (p=0.001), by 73.9% in diastolic BP (DBP) (p<0.001) and by 68.5% in mean BP (MBP) (p<0.001). For patients with rFTD not necessarily equal to 0 seconds, every 10 mm Hg increase in BP, there was a 7% decrease in expected count of seconds for rFTD in SBP (p=0.002), 10% decrease for rFTD in DBP and 11% decrease for rFTD in MBP. The arterial occlusion location and OCT showed no significant interaction in the BP-rFTD relationship (p>0.05). CONCLUSIONS: In acute ischemic stroke, higher ABP is possibly associated with improved leptomeningeal collaterals as identified by decreased rFTD.
Arterial Pressure
;
Blood Pressure*
;
Humans
;
Perfusion
;
Reperfusion*
;
Retrospective Studies
;
Stroke*
3.DIRECT-SAFE: A Randomized Controlled Trial of DIRECT Endovascular Clot Retrieval versus Standard Bridging Therapy
Peter J. MITCHELL ; Bernard YAN ; Leonid CHURILOV ; Richard J. DOWLING ; Steven BUSH ; Thang NGUYEN ; Bruce C.V. CAMPBELL ; Geoffrey A. DONNAN ; Zhongrong MIAO ; Stephen M. DAVIS ;
Journal of Stroke 2022;24(1):57-64
Background:
and Purpose The benefit regarding co-treatment with intravenous (IV) thrombolysis before mechanical thrombectomy in acute ischemic stroke with large vessel occlusion remains unclear. To test the hypothesis that clinical outcome of ischemic stroke patients with intracranial internal carotid artery, middle cerebral artery or basilar artery occlusion treated with direct endovascular thrombectomy within 4.5 hours will be non-inferior compared with that of standard bridging IV thrombolysis followed by endovascular thrombectomy.
Methods:
To randomize 780 patients 1:1 to direct thrombectomy or bridging IV thrombolysis with thrombectomy. An international-multicenter prospective randomized open label blinded endpoint trial (PROBE) (ClincalTrials.gov identifier: NCT03494920).
Results:
Primary endpoint is functional independence defined as modified Rankin Scale (mRS) 0–2 or return to baseline at 90 days. Secondary end points include ordinal mRS analysis, good angiographic reperfusion (modified Thrombolysis in Cerebral Infarction score [mTICI] 2b–3), safety endpoints include symptomatic intracerebral hemorrhage and death.
Conclusions
DIRECT-SAFE will provide unique information regarding the impact of direct thrombectomy in patients with large vessel occlusion, including patients with basilar artery occlusion, with comparison across different ethnic groups.
4.Autoimmunity in acute ischemic stroke and the role of blood-brain barrier: the dark side or the light one?
Nikolay V TSYGAN ; Alexandr P TRASHKOV ; Igor V LITVINENKO ; Viktoriya A YAKOVLEVA ; Alexandr V RYABTSEV ; Andrey G VASILIEV ; Leonid P CHURILOV
Frontiers of Medicine 2019;13(4):420-426
This article presents a synopsis of the current data on the mechanisms of blood-brain barrier (BBB) alteration and autoimmune response in acute ischemic stroke. Most researchers confirm the relationship between the severity of immunobiochemical changes and clinical outcome of acute ischemic stroke. Ischemic stroke is accompanied by aseptic inflammation, which alters the brain tissue and exposes the co-stimulatory molecules of the immune system and the neuronal antigens. To date, BBB is not considered the border between the immune system and central nervous system, and the local immune subsystems are found within and behind the BBB. BBB disruption contributes to the leakage of brain autoantigens and induction of secondary autoimmune response to neuronal antigens and long-term inflammation. Glymphatic system function is altered and jeopardized both in hemorrhagic and ischemic stroke types. The receptors of innate immunity (toll-like receptor-2 and toll-like receptor-4) are also involved in acute ischemia-reperfusion injury. Immune response is related to the key processes of blood clotting and fibrinolysis. At the same time, the stroke-induced immune activation may promote reparation phenomena in the brain. Subsequent research on the reduction of the acute ischemic brain injury through the target regulation of the immune response is promising.